Stay up to date:


Peter Heinrich

Peter Heinrich

Managing Director and Partner at Sinfonie Life Science Management GmbH and Chairman of the Board of Directors at Injex Pharma AG. Peter has a PhD in Biology and Chemistry from the Ludwig-Maximilians Universität in München and is co-founder and chairman of the executive board of BIO-Deutschland, an independent organization representing the interests of the German biotechnology industry. From 2001 to 2009 he was member of European Biopharmaceutical Enterprises (EBE), and its president from 2003 to 2006. He has been a Board Member of EuropaBio since June 2010, and a Member of the Board of Trustees of Bayern Innovativ GmbH. Peter is also a mentor and tutor at the Bavarian Elite Academy, and a member of the Supervisory Board of the University of Augsburg’s MBA program. LinkedIn

Andy Porter

Prof. Andrew Porter

Professor of Medical Biotechnology, University of Aberdeen, Scotland and Director of the Scottish Biologics Facility. Andrew is also the CTO of the biologics company Elasmogen Ltd with programs in ophthalmology, inflammation and oncology. He was the founder and CSO of Haptogen Ltd. until it was acquired, in October 2007, by Wyeth Inc.  In 2005 he was made the Ernst and Young Plc, UK Science and Technology Entrepreneur of the Year.  In 2006 he was became a Fellow of the Royal Society of Edinburgh and a Fellow of the Royal Society of Biology in 2012.  Andrew has been on the Board of NovaBiotics Ltd since 2009.  NovaBiotics recently announced the successful completion of its Phase 2b Cystic Fibrosis trial for Lynovex™ and won EuropaBio’s most innovative SME in 2017.  Outside of bioscience, and with a team of young industry savvy entrepreneurs, Andy has established a portfolio of award winning cocktail bars (top 100 in the world) and opened Langstrane Liquor Ltd in 2015, Aberdeen’s first gin distillery for 100 years.  Andy is a graduate of St Andrew’s University, Scotland. LinkedIn

Paul Rubig

MEP Dr. Paul Rübig

Austrian Member of the European Parliament since 1996, belonging to the European People’s Party (EPP). Paul is a full member of the Committee on Industry, Research and Energy and the Committee on Budgets, and is very active in the field of the small-scale business promotion. He is president of SME Global, a working group of the International Democrat Union (IDU), whose objective it is to support small and medium-sized enterprises and to improve their business environment. Since 2014, he has been the Chairman of STOA (Scientific Technology Options Assessment), an official body of the European Parliament that is supported by external experts such as universities, scientists or research institutes. Last but not least, he is Co-Chairman of the EPP medium-sized businesses in the Steering Committee on the WTO. LinkedIn


Joanna Dupont-Inglis

Joanna Dupont-Inglis is the Secretary General of EuropaBio, the European Association of Bioindustries. Since arriving in 2009, Dupont-Inglis has worked with the Associations healthcare, agricultural and industrial biotech sectors, as well as with its National Associations Council and SME Platform. Prior to her current role, Joanna was Director for the Industrial Biotech sector for several years, during which time she helped lead industry efforts to create the first €3.7 billion Bio-Based Industries Joint Undertaking (BBI JU), chaired the EU Bioeconomy Stakeholder’s Panel and was a board member of SusChem. Before arriving at EuropaBio, she has been working for two Brussels-based consultancies, in the environmental, agricultural, healthcare, development and energy efficiency sectors. LinkedIn

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.